Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...

The key to treating congestive heart failure is addressing the underlying causes, and treatment is highly tailored to each ...

Findings highlight the importance of infection prevention measures and personalized heart failure care.

The following is a summary of “Impact of Exercise on Atrial Functional Mitral Regurgitation and Its Determinants: An Exercise ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart ...

In particular, severe infections tripled the risk of heart failure with preserved ejection fraction (HFpEF), which occurs ...

Researchers discovered that ALPK2, a heart-specific enzyme, may protect against HFpEF by activating TPM1 in heart muscle ...

Heart failure remains a substantial burden for patients due to its high prevalence and limited therapeutic options. Heart failure is classified into two major clinical subtypes- heart failure with ...

The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

A recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, ...

Danielle Rasooly, PhD, of the Division of Aging at Brigham and Women’s Hospital, is the co-corresponding author of a paper published in Nature Cardiovascular Research, “Large-scale multi-omics ...